Hundreds ADPKD patients harbor PKD2 gene truncating mutations, such as the Tawain founder variant, which confer variable cystogenic propensity driven by differences in molecular dysfunction and primary cilia localization. Here, PKD2 is linked to autosomal dominant polycystic kidney disease.